BioNTech aims to advance pipeline to the clinic with $325m investment
BioNTech completed a $325m Series B financing rounds as the biotech looks to advance its therapeutics pipeline and manufacturing capabilities.
Archives for July 10, 2019
Emergex develops synthetic hand-foot-and-mouth vaccine
In collaboration with a research center, Emergex will apply its synthetic development approach on a vaccine against hand, foot and mouth disease.